The weekly combination therapy is intended for adults with poor glucose control despite basal insulin or GLP-1 receptor agonist treatment.

New York City became the first city in the country to allow supervised drug use sites where people can use illegal drugs without threat of arrest, under the watch of trained staff, Mayor Bill de ...

Canakinumab (Ilaris) may be the better option than anakinra (Kineret) when treating the rare disease called VEXAS syndrome ...

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option ...

Viatris Inc. (NASDAQ:VTRS), formed from the 2020 merger of Mylan and Pfizer’s Upjohn division, delivers essential generic and specialty medicines to patients in over 165 countries.